What Is Amanin? Definition and What Research Reports

Amanin is the name given to a naturally occurring bicyclic octapeptide that belongs to the amatoxin group — a small family of cyclic peptide toxins produced by certain mushrooms, most famously in the genera Amanita, Lepiota and Galerina. Structurally it sits alongside better-known relatives such as α-amanitin and β-amanitin, and it is sometimes listed in analytical tables next to its amide counterpart, amaninamide. Amanin is not a synthetic laboratory peptide, not a drug, and not a supplement ingredient: it is a fungal secondary metabolite, and essentially all of the published literature that mentions it is analytical, taxonomic or toxicological in nature. This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question.

What class of molecule is amanin?

Amanin is described in the chemical literature as a bicyclic octapeptide: eight amino acid residues arranged in a macrocyclic ring, cross-braced by a second bridge that links a tryptophan-derived residue to a sulfur atom from cysteine (the tryptathionine bridge). That bridge, plus extensive post-translational hydroxylation, is what distinguishes amatoxins from ordinary linear peptides and gives them unusual chemical and thermal stability. Amatoxins are generally classified as ribosomally synthesised and post-translationally modified peptides, meaning the fungus builds a short precursor protein and then processes it into the mature cyclic toxin.

Within the amatoxin family, individual members differ only by small substitutions — a hydroxyl group present or absent on one residue, or a free carboxylic acid where another member carries an amide. Amanin is usually described as a close structural analogue of β-amanitin, differing in the hydroxylation pattern of the indole-containing residue, with amaninamide representing the corresponding amide form. Because the differences are subtle, amanin is typically identified in practice by chromatographic retention time together with mass spectrometric detection rather than by appearance or simple colour tests.

Where amanin comes from

Amanin is a fungal product. It is not manufactured for consumer use, it has no approved medical product built around it, and it does not appear in the literature as a compound administered to human volunteers. Analytical studies isolate it — or look for it and fail to find it — in dried or fresh mushroom tissue. A 2026 report in Toxicon examined the toxin content of Amanita vidua specimens collected in Türkiye, characterising which amatoxins and phallotoxins were present in that species (PMID 41371304). Work of this kind is how the distribution of amanin and its relatives across species and regions has been mapped.

How the term is used in peptide research

In the wider peptide field, "amanin" appears in three fairly narrow contexts:

• As a reference standard. Amatoxin analysis requires authentic standards for each congener, so amanin is listed in method papers as one of the analytes screened alongside α-, β- and γ-amanitin, phalloidin and phallacidin.
• As a chemotaxonomic marker. Which amatoxins a mushroom contains, and in what pattern, helps mycologists describe and separate species.
• As an example in peptide chemistry teaching. The tryptathionine cross-link and the rigid bicyclic scaffold are frequently used to illustrate how nature stabilises small peptides.

What amanin is not is a "research peptide" in the way that term is used for synthetic analogues of human hormones. It has no reported role as an investigational agent for metabolic, cosmetic or performance endpoints, and the published record contains no human dosing studies of amanin as a standalone compound.

What the published literature reports

Profiling work in the genus Lepiota

Much of the modern analytical literature on amatoxins comes from surveys of small Lepiota species. Researchers profiling amatoxins and phallotoxins across the genus used liquid chromatography combined with UV absorbance and mass spectrometry detection to determine which species carried these cyclic peptides and which did not (PMID 25098279). A later paper applied high-performance liquid chromatography coupled with mass spectrometry to determine amatoxins specifically in Lepiota brunneoincarnata and Lepiota venenata, reporting the toxin profile measured in those collections (PMID 37970561).

Species reported to lack amatoxins

Negative findings matter just as much in this field. The study of Lepiota castanea growing in Türkiye reported that the analysed material did not contain phallotoxins or amatoxins at detectable levels, a result that separates that species from its toxin-bearing relatives (PMID 38670498). Taken with the genus-wide profiling work, this illustrates a consistent theme in the literature: amatoxin content varies by species, and in some cases by collection site, so presence cannot be assumed from genus alone (PMID 25098279).

Amanin in relation to other amatoxins

Safety Context: What Studies Report

The published record on amanin is analytical rather than clinical, so it does not describe adverse-event rates, thresholds or exposure outcomes in people for this specific congener. What the studies do establish is classification: amanin is grouped with compounds that journals such as Toxicon treat as mushroom toxins, and the analytical papers exist precisely because identifying these peptides in mushroom tissue is treated as a toxicological question (PMID 41371304). Researchers screening Lepiota species framed the work the same way, measuring amatoxin and phallotoxin content as a way of distinguishing toxin-bearing from non-toxin-bearing material (PMID 37970561). No study in this set reported an administered dose of amanin in animals or humans, and none is summarised here as if it had.

Common points of confusion

1. Amanin is not amanitin. They are different congeners in the same family; abstracts and analytical tables name them separately.
2. Amanin is not a phallotoxin. Phallotoxins such as phalloidin are heptapeptides and are reported as a distinct analyte class in profiling studies (PMID 25098279).
3. Genus does not predict content. The study of Lepiota castanea from Türkiye reported no detectable amatoxins or phallotoxins, while other Lepiota species in the same literature were reported to contain them (PMID 38670498).
4. It is not a wellness or performance compound. Amanin appears in toxicology and mycology journals, not in trials of peptide therapeutics.

Summary

Amanin is best understood as a definitional entry rather than a topic with a body of intervention research behind it: a bicyclic octapeptide amatoxin of fungal origin, identified by chromatographic and mass spectrometric methods, and studied mainly to characterise which mushroom species contain which toxins (PMID 25098279). Again, this page is educational only and is not medical advice.

References

• Lepiota castanea mushroom growing in Turkiye does not contain phallotoxins and amatoxins (Toxicon, 2024)
• Toxin content of Amanita vidua from Türkiye (Toxicon, 2026)
• Determination of Amatoxins in Lepiota brunneoincarnata and Lepiota venenata by High-Performance Liquid Chromatography Coupled with Mass Spectrometry (Mycobiology, 2020)
• Profiling of amatoxins and phallotoxins in the genus Lepiota by liquid chromatography combined with UV absorbance and mass spectrometry (Toxins, 2014)